Arteris, Inc. (NASDAQ:AIP – Get Free Report) Director Saiyed Atiq Raza sold 1,136 shares of the business’s stock in a transaction dated Friday, July 18th. The stock was sold at an average price of $10.00, for a total value of $11,360.00. Following the transaction, the director directly owned 682,662 shares of the company’s stock, valued at approximately $6,826,620. The trade was a 0.17% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Saiyed Atiq Raza also recently made the following trade(s):
- On Friday, June 27th, Saiyed Atiq Raza sold 19,809 shares of Arteris stock. The shares were sold at an average price of $10.02, for a total value of $198,486.18.
Arteris Stock Performance
Shares of AIP opened at $9.57 on Thursday. The stock has a market cap of $401.75 million, a PE ratio of -11.67 and a beta of 1.44. Arteris, Inc. has a fifty-two week low of $5.46 and a fifty-two week high of $12.64. The firm’s 50-day simple moving average is $8.56 and its two-hundred day simple moving average is $8.50.
Institutional Trading of Arteris
Wall Street Analysts Forecast Growth
Separately, Rosenblatt Securities reiterated a “buy” rating and issued a $14.00 target price on shares of Arteris in a research note on Wednesday, May 21st.
View Our Latest Research Report on Arteris
About Arteris
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Featured Articles
- Five stocks we like better than Arteris
- Roth IRA Calculator: Calculate Your Potential Returns
- Rocket Lab: A Parabolic Run Meets a Healthy Pullback
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Falling Fast, Rising Soon? 3 Stocks With Upside Ahead
- How to Invest in Biotech Stocks
- The Top 120 Lesser-Known Affordable Luxury Vacation Spots in the U.S.
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.